Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin starting-dose evaluation in pediatric oncology patients
NL-OMON40472Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2014
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Trial of vancomycin, sponsored by Amsterdam University Medical Center. Started Jun 2014; status: active, not recruiting.
02
Drugs
vancomycin
Beyond the preview
Go deeper on NL-OMON40472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40472.